Cabazitaxel contains not less than 98.0 percent and not more than 102.0 percent of C45H57NO14, calculated on the anhydrous basis.

"永信"卡巴紫杉醇
Cabazitaxel "Yung Shin"

• 申請商: 永信藥品工業股份有限公司
• 適應症: 抗腫瘤藥及免疫製劑。
• 含量: 0